| # | Drug | Count |
|---|---|---|
| 0 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 208 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE | 204 |
| 2 | DAPAGLIFLOZIN | 99 |
| 3 | ASPIRIN | 95 |
| 4 | FUROSEMIDE | 95 |
| 5 | ASPIRIN 325 MG | 93 |
| 6 | ASPIRIN 81 MG | 93 |
| 7 | METFORMIN | 76 |
| 8 | APIXABAN | 73 |
| 9 | ALLOPURINOL | 71 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALUMINUM HYDROXIDE GEL | 7 | 0.0476 |
| 1 | TEDIZOLID PHOSPHATE | 11 | 0.0137 |
| 2 | ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE | 1 | 0.0086 |
| 3 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 69 | 0.0069 |
| 4 | 1.1% SODIUM FLUORIDE PRESCRIPTION DENTAL CREAM | 1 | 0.0060 |
| 5 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 19 | 0.0053 |
| 6 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 47 | 0.0052 |
| 7 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 33 | 0.0049 |
| 8 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 54 | 0.0047 |
| 9 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 13 | 0.0047 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 270 | 0.0025 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 114 | 0.0019 |
| 3 | Provitamin D2 Compound [EPC] | 56 | 0.0019 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 5 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 6 | Uric Acid-specific Enzyme [EPC] | 5 | 0.0013 |
| 7 | Lipopeptide Antibacterial [EPC] | 12 | 0.0013 |
| 8 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 9 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 115 | 0.0011 |